director-officer-questionnaire
Drafts Director and Officer (D&O) questionnaires for SEC disclosure compliance under Reg S-K Items 401, 402, 404, and 407. Covers biographical data, board service, conflicts of interest, related party transactions, legal proceedings, and beneficial ownership. Use when preparing annual proxy questionnaires, pre-IPO governance documentation, M&A due diligence packages, or independence assessments.
Best use case
director-officer-questionnaire is best used when you need a repeatable AI agent workflow instead of a one-off prompt.
Drafts Director and Officer (D&O) questionnaires for SEC disclosure compliance under Reg S-K Items 401, 402, 404, and 407. Covers biographical data, board service, conflicts of interest, related party transactions, legal proceedings, and beneficial ownership. Use when preparing annual proxy questionnaires, pre-IPO governance documentation, M&A due diligence packages, or independence assessments.
Teams using director-officer-questionnaire should expect a more consistent output, faster repeated execution, less prompt rewriting.
When to use this skill
- You want a reusable workflow that can be run more than once with consistent structure.
When not to use this skill
- You only need a quick one-off answer and do not need a reusable workflow.
- You cannot install or maintain the underlying files, dependencies, or repository context.
Installation
Claude Code / Cursor / Codex
Manual Installation
- Download SKILL.md from GitHub
- Place it in
.claude/skills/director-officer-questionnaire/SKILL.mdinside your project - Restart your AI agent — it will auto-discover the skill
How director-officer-questionnaire Compares
| Feature / Agent | director-officer-questionnaire | Standard Approach |
|---|---|---|
| Platform Support | Not specified | Limited / Varies |
| Context Awareness | High | Baseline |
| Installation Complexity | Unknown | N/A |
Frequently Asked Questions
What does this skill do?
Drafts Director and Officer (D&O) questionnaires for SEC disclosure compliance under Reg S-K Items 401, 402, 404, and 407. Covers biographical data, board service, conflicts of interest, related party transactions, legal proceedings, and beneficial ownership. Use when preparing annual proxy questionnaires, pre-IPO governance documentation, M&A due diligence packages, or independence assessments.
Where can I find the source code?
You can find the source code on GitHub using the link provided at the top of the page.
SKILL.md Source
# Director and Officer Questionnaire Drafts structured D&O questionnaires for SEC filings, proxy statements, conflict assessments, and transaction due diligence. ## Quick Start Gather before drafting: 1. **Company profile** — public/private, exchange listing, regulated industry status 2. **Prior questionnaires** — existing D&O questionnaires, proxy statements, Form 10-K bios 3. **Governance docs** — articles, bylaws, code of ethics, related party transaction policy, insider trading policy 4. **Disclosure baseline** — latest proxy statement, director/officer roster, committee assignments 5. **Purpose** — annual proxy, IPO prep, M&A due diligence, or governance record ## Questionnaire Sections ### Cover Page - Company name, questionnaire purpose, submission deadline, designated contact - Confidentiality notice: information may appear in SEC filings, be shared with auditors/counsel/counterparties - Continuing obligation: report material changes within **5 business days** ### Key Definitions | Term | Definition | |------|------------| | Immediate family | Spouse, domestic partner, parents, stepparents, children, stepchildren, siblings, in-laws, household members (excl. tenants/employees) | | Beneficial ownership | Direct + indirect ownership per Rule 13d-3 including trusts, family, controlled entities | | Related party transaction | Transaction exceeding threshold where related person has direct/indirect material interest (Item 404) | | Material | Information a reasonable shareholder would consider important; err toward disclosure | ### I — Personal and Identifying Information - Full legal name; former names/aliases (past 10 years) - Business address (public filings); residential address (confidential) - Contact info; DOB; citizenship/residency - Tax ID/SSN (limited use — store under data security controls) - Family relationships with other directors, officers, >5% shareholders (Item 401(d)) ### II — Professional Background - Current role: title, appointment date, reporting relationships, material changes in past fiscal year - Employment history — **10 years** (5 years required by Item 401(e); 10 recommended for due diligence) - Education, professional licenses, bar admissions (include disciplinary history) - Qualifications narrative for proxy biographical disclosure per Item 401(e) ### III — Board Service and External Positions All directorships, trusteeships, advisory roles, officer positions — **past 10 years**: - Public companies: ticker, exchange, principal business - Audit committee financial expert designation (Item 407(d)(5)) - Lead independent director, non-executive chair, presiding director roles - Attendance records; industry association service **Adverse events during tenure** (Item 401(f) — 10-year look-back; serious matters regardless of timing): - Bankruptcy/receivership/insolvency at organizations where respondent served - SEC or regulatory enforcement actions, consent orders - Financial statement restatements, material litigation, regulatory sanctions - Decisions not to stand for reelection or pre-term resignations ### IV — Conflicts and Related Party Transactions *(Item 404 — threshold currently $120,000 for public companies [VERIFY])* Disclose for respondent, immediate family, or controlled entities: - **Business relationships**: goods/services, consulting, leases, loans, charitable contributions - **Competing interests**: roles at competitors, financial interest in customers/suppliers/lenders/targets, corporate opportunities taken without board approval - **Indebtedness**: company loans to respondent/family (SOX Section 402 prohibits loans to executive officers of public companies [VERIFY exemptions]); company guarantees - **Independence-impairing relationships**: auditor connections (past 3 years), interlocking directorates, significant personal relationships affecting perceived independence ### V — Legal Proceedings and Regulatory Matters *(Item 401(f) — 10-year look-back; certain matters regardless of timing)* - **Criminal**: convictions, guilty/nolo pleas, DPAs, pending charges (excl. minor traffic) - **Civil litigation**: fraud, misrepresentation, breach of fiduciary duty, securities/banking violations - **Regulatory**: SEC, DOJ, FINRA, OCC, FDIC, FDA, state regulators — enforcement actions, consent orders, bars, penalties - **Professional**: bar disciplinary, CPA/PCAOB proceedings, licensing actions - **Other**: Wells notices, restatement involvement, internal control deficiencies *Disclose regardless of outcome. Non-disclosure creates greater risk than over-disclosure.* ### VI — Financial Interests and Securities - **Beneficial ownership** (Rule 13d-3): direct + indirect holdings by security class - **Equity compensation**: options (vested/unvested), RSUs, PSUs, SARs — grant dates, vesting, expiration - **Transactions**: pledged shares, hedging arrangements, short sales/derivatives, Rule 10b5-1 plans - **Perquisites**: aircraft/vehicle use, club memberships, financial planning, tax gross-ups, non-standard indemnification *Supports: proxy ownership tables; Forms 3, 4, 5; Item 402 compensation; Item 404 related party disclosure.* ### VII — Certification and Signature Respondent certifies: - All information true, complete, and accurate - No material omissions - Will notify Corporate Secretary/General Counsel within **5 business days** of changes - Understands use in SEC filings, audit, and due diligence - Agrees to comply with code of ethics, insider trading policy, governance guidelines - Acknowledges fiduciary duties of care and loyalty *Electronic signatures must comply with the E-SIGN Act and UETA.* ## Pitfalls and Checks - **Regulated industries**: add enhanced sections for financial services (Fed/OCC, FINRA), healthcare (FDA, DEA), defense (security clearances), energy - **Public vs. private**: Item references apply to public companies; private companies contemplating IPO/M&A should collect in public-company format proactively - **Look-back period**: 10 years for Item 401(f) legal proceedings; recommended for employment/board history (exceeds 5-year Item 401(e) minimum) - **Independence**: cross-reference applicable NYSE/Nasdaq listing standards - **Annual updates**: structure for year-over-year refresh — flag stable bio data vs. fields needing annual review - **Privacy**: SSN/DOB under data security controls; reference CCPA in confidentiality notice; limit access to need-to-know - **Materiality**: when uncertain, err toward disclosure — counsel evaluates significance
Related Skills
past-performance-questionnaire
Drafts a Past Performance Questionnaire for evaluating legal service providers or contractors in government contract contexts. Trigger when the user needs vendor evaluation instruments, contractor performance reviews, past performance assessments, or due diligence questionnaires aligned with FAR requirements.
medical-director-agreement
Drafts a Medical Director Agreement between a healthcare organization and a physician, structured for Anti-Kickback Statute and Stark Law safe harbor compliance. Covers appointment, duties, FMV compensation, independent contractor status, restrictive covenants, HIPAA obligations, and regulatory safeguards for hospitals, ASCs, SNFs, and other facilities. Use when drafting medical director contracts, physician administrative services agreements, or healthcare leadership engagement letters.
director-indemnification
Drafts indemnification agreements between corporations and directors covering expense advancement, indemnification determinations, D&O insurance coordination, and successor obligations. Use when drafting director indemnification agreements, expense advancement provisions, or D&O indemnity contracts.
director-indemnification-agreement
Drafts U.S. director indemnification agreements maximizing protection under state corporate law, with advancement of expenses and determination procedures. Use when drafting or updating a director indemnification agreement, onboarding directors, strengthening governance beyond bylaws, or coordinating with D&O coverage. Triggers: indemnification agreement, director advancement, corporate governance, D&O, DGCL 145.
skill-name
Replace with a specific description of what this skill does and when to use it. Include keywords that help agents identify relevant tasks.
writing-surgical-consultation-notes
Creates structured surgical consultation responses with assessment and surgical candidacy determination. Use when responding to surgical consults, evaluating surgical candidates, or documenting surgical recommendations.
writing-operative-reports
Creates structured operative notes with findings, technique, specimens, and estimated blood loss. Use when dictating operative reports, documenting surgical procedures, or recording intraoperative findings.
writing-irb-submissions
Creates IRB submission packages with protocol summaries, consent forms, and risk-benefit analysis. Use when submitting to IRB, preparing ethics applications, or writing consent documents.
writing-grant-applications-research
Structures NIH/foundation grant applications with specific aims, significance, and innovation sections. Use when writing research grants, preparing NIH applications, or structuring grant proposals.
writing-admission-orders
Generates structured admission order sets with diagnosis-specific protocols and safety checks. Use when admitting patients, creating admission orders, or setting up inpatient care plans.
validating-new-laboratory-tests
Structures test validation with precision, accuracy, linearity, and reference range establishment. Use when validating new assays, documenting method comparisons, or establishing reference ranges.
validating-clinical-data-quality
Structures data quality assessment with completeness, accuracy, and consistency validation. Use when auditing clinical data, assessing data quality, or validating data integrity.